Evidence map›Paper›PMID 42324465›Full record

ArticleJournal of experimental & clinical cancer research : CR2026

Correction: Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.

Nian Liu, Kuan Song Wang, Min Qi, Ying Jun Zhou, Guang Yao Zeng, Juan Tao, Jian Da Zhou, Jiang Lin Zhang, Xiang Chen, Cong Peng

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Nian Liu *Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Kuan Song Wang *Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Min QiDepartment of Plastic and Cosmetic Surgery, XiangYa Hospital, Central South University, Changsha, Hunan, China.
Ying Jun ZhouSchool of Pharmaceutical Science, Central, South University, Changsha, Hunan, China.
Guang Yao ZengSchool of Pharmaceutical Science, Central, South University, Changsha, Hunan, China.
Juan TaoDepartment of Dermatology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jian Da ZhouDepartment of Plastic Surgery of Third Xiangya Hospital, Central South University, Changsha, China.
Jiang Lin ZhangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. leozjl1010@126.com.
Xiang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. chenxiangck@gmail.com.
Cong PengDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. pengcongxy@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42324465
PMCPMC13285011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.